Status:
COMPLETED
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
Lead Sponsor:
Poitiers University Hospital
Conditions:
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cancer is a well known complication about long term transplantation. Cancer outcomes are due to the immunosuppressive treatment that prevents transplanted people from rejection. By lowering the effect...
Eligibility Criteria
Inclusion
- Patients over 18
- Patients with kidney transplantation for 10 year
- Patients with stable renal function (less than 20% creatinine variation during the last 12 months)
- Patients treated either by a corticosteroid - azathioprine association or cyclosporine A
- Patients giving his agreement
- Patients legally free
Exclusion
- Patients under 18
- Patients under legal protection
- Pregnant women, or of age to get pregnant
Key Trial Info
Start Date :
January 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 7 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03227965
Start Date
January 13 2017
End Date
February 7 2019
Last Update
April 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Poitiers
Poitiers, France, 86000